Table 3.
Study first author (ref. no) | Rat hypertension model | Allopurinol administration | BP measurement | BP effect |
---|---|---|---|---|
Nakazono et al. (13) | SHR | Acute - iv - 17 mg/kg | Tail cuff - one timepoint | lower SBP |
Yamamoto et al. (18) | SHR | Chronic - oral - 30 mg/kg/day | Tail cuff - two timepoints |
No effect |
Laakso et al. (17) | SHR on high-salt diet | Chronic - oral - 10 mg/kg/day | Tail cuff - one timepoint | No effect |
Wallwork et al. (15) | Dexamethasone | Chronic - oral - 20–25 mg/day | Direct arterial - one timepoint |
Lower SBP and MAP |
Ong et al. (20) | Dexamethasone | Chronic - oral - 200 mg/kg/day | Tail cuff - timecourse | No effect |
Viel et al. (14) | DOCA-salt | Chronic - oral - 100 mg/kg/day | Tail cuff - one timepoint | Lower SBP |
Tian et al. (19) | Dahl-salt sensitive | Chronic - oral - 10 mg/kg/day | Direct arterial - timecourse |
No effect |
Kasal et al. (21) | L-NAME | Chronic -oral - 40 mg/kg/day | Tail cuff - three timepoints |
No effect |
Zhang et al. (22) | ACTH | Chronic -oral - 200 mg/kg/day | Tail cuff - timecourse | No effect |
Minami et al. (23) | Hypercholesterolemia | Chronic - oral - 10 mg/kg/day | Tail cuff - timecourse | No effect |